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CHAPTER 5
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ABSTRACT 
The transcription factor NF-κB plays a critical role in the inflammatory response and it has 
been implicated in various diseases, including non-alcoholic fatty liver disease (NAFLD). 
Although transient NF-κB activation may protect tissues from stress, a prolonged NF-
κB activation can have a detrimental effect on tissue homeostasis and therefore accurate 
termination is crucial. Copper Metabolism MURR1 Domain-containing 1 (COMMD1), 
a protein with functions in multiple pathways, has been shown to suppress NF-κB activity. 
However, its action in controlling liver inflammation has not yet been investigated. 
To determine the cell-type-specific contribution of Commd1 to liver inflammation, we used 
hepatocyte and myeloid-specific Commd1-deficient mice. We also used a mouse model 
of NAFLD to study low-grade chronic liver inflammation: we fed the mice a high fat, high 
cholesterol (HFC) diet, which results in hepatic lipid accumulation accompanied by liver 
inflammation. Depletion of hepatocyte Commd1 resulted in elevated levels of the NF-κB 
transactivation subunit p65 (RelA) but, surprisingly, the level of liver inflammation was 
not aggravated. In contrast, deficiency of myeloid Commd1 exacerbated diet-induced 
liver inflammation. Unexpectedly we observed that hepatic and myeloid Commd1 
deficiency in the mice both augmented hepatic lipid accumulation. The elevated levels 
of proinflammatory cytokines in myeloid Commd1-deficient mice might be responsible 
for the increased level of steatosis. This increase was not seen in hepatocyte Commd1-
deficient mice, in which increased lipid accumulation appeared to be independent 
of inflammation. Our mouse models demonstrate a cell-type-specific role for Commd1 
in suppressing liver inflammation and in the progression of NAFLD.
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INTROdUCTION
The Copper Metabolism Murr1 Domain-containing protein 1 (COMMD1) is the founder 
member of a relatively new family of proteins, the COMMD family [1]. This protein family 
is distinguished by a unique motif called the COMM domain, located at their carboxy-
terminus. Recent studies have demonstrated that COMMD1 acts in a wide variety of cellular 
processes, including hepatic copper transport [2, 3], hypoxia response [4-6], sodium, potassium 
and chloride transport [7-10], and in nuclear factor kappa B (NF-κB) signaling [11]. 
We recently confirmed its role in hepatic copper homeostasis in liver-specific Commd1 knockout 
mice [12]. On depletion of Commd1 in hepatocytes, mice become susceptible to hepatic copper 
accumulation [12], similar to dogs carrying a homozygous COMMD1 loss-of-function mutation 
[2]. Notwithstanding its role in copper transport, the biological role of COMMD1 in NF-κB 
signaling in the liver and in inflammatory liver diseases has not yet been defined.
The NF-κB family of transcription factors plays a key role in the inflammatory responses. 
The family consists of five members, of which p65 (RelA) and p50/p105 (NF-κB1) compose 
the canonical NF-κB pathway. The p65/p50 heterodimer is sequestered in the cytoplasm 
by the inhibitory IκB proteins. Activation of the canonical NF-κB pathway via the kinase 
complex IKK results in translocation of p65/p50 dimer to the nucleus for transcriptional 
activation of its target genes. COMMD1 has been shown to terminate NF-κB activity 
by acting as a scaffold protein in the E3 ubiquitin ligase complex (ECSSOCS1) [1, 13]. ECSSOCS1 
promotes ubiquitination and subsequent proteasomal degradation of p65 and destabilizes 
the interaction between p65 and chromatin. Hence, depletion of COMMD1 results 
in elevated p65 levels and subsequently increased NF-κB activity [1, 13, 14].
The NF-κB signaling pathway has a remarkable physiological function in several liver diseases, 
including non-alcoholic fatty liver disease (NAFLD) [15]. NAFLD consists of a wide spectrum 
of pathologies, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), 
and can even progress to liver fibrosis and cirrhosis, and in some cases to hepatocellular carcinoma 
(HCC) [16]. The progression to the severe stages of NAFLD, which are related to a poor prognosis, 
is thought to be driven by inflammation, including the expression of the NF-κB-mediated cytokines 
Il-6 and Tnf-α [16-18]. These proinflammatory cytokines are mainly secreted by activated 
Kupffer cells, the resident liver macrophages, and they promote the progression of NAFLD 
towards NASH [19, 20]. In addition, the NF-κB signaling pathway in hepatocytes also plays a role 
in NAFLD progression, as hepatocyte-specific depletion of NEMO, the regulatory subunit of the IKK 
complex, results in chronic steatohepatitis and eventually leads to the formation of liver tumors 
[21]. Together these findings underscore the pivotal role of the NF-κB signaling pathway in health 
and disease, but the contribution of COMMD1 in hepatocyte NF-κB signaling and in inflammatory 
liver diseases still remains elusive. To determine the cell-type-specific role of COMMD1 in liver 
inflammation, we used hepatic and myeloid-specific Commd1-deficient mice and a second mouse 
model of NAFLD for low-grade, chronic liver inflammation. In these different mouse models, 





Conditional hepatocyte-specific (Commd1∆Hep) [12] and conditional myeloid-specific knockout 
mice (Commd1∆Mye) were obtained by crossing Commd1loxP/loxP mice (here referred to as wild 
type (WT) mice) with Albumin-Cre [22] or LysM-Cre [23] transgenic mice, respectively. Both 
Commd1∆Hep and Commd1∆Mye mice were backcrossed in a C57BL/6J background for more 
than 8 generations. Commd1loxP/loxP littermate mice (WT) served as controls for Commd1∆Hep 
and Commd1∆Mye mice. p55∆ns/∆ns ; Commd1∆Hep were obtained by crossing p55∆ns/∆ns [24] 
with Commd1∆Hep mice. All the experimental mice were males and were housed individually. 
They were fed ad libitum with either standard rodent chow diet (RMH-B, AB Diets, Woerden, 
the Netherlands), or, starting at 8-10 weeks of age, a high-fat, high-cholesterol (HFC) diet (45% 
calories from butter fat) containing 0.2% cholesterol (SAFE Diets) for a period of 12 weeks. 
p55∆ns/∆ns ; Commd1∆Hep and p55∆ns/∆ns mice were fed only a chow diet and were sacrificed at the age 
of 20 weeks. All animals were sacrificed following a 4-hour morning fasting period. Body weight 
and liver weight measurements were recorded. Collected tissues were snap-frozen in liquid nitrogen 
and blood was collected by means of heart puncture in K3EDTA-coated MiniCollect® tubes 
(#450476, Greiner Bio-One, Alphen a/d Rijn, the Netherlands). The right hepatic lobe was used 
for gene expression, immunoblot and histological analysis. Plasma was separated by centrifuging 
at 3000 rpm for 10 min. at 40C. All animal-related studies were approved by the Institutional 
Animal Care and Use Committee of the University of Groningen (Groningen, the Netherlands).
liVer NUCleAr AND CytOSOliC frACtiON iSOlAtiON , DNA BiNDiNG eliSA
Fractionation was performed on fresh, ice-cold, mouse liver samples, using the Nuclear 
Extract Kit (#40010, Active Motif, La Hulpe, Belgium) according to the manufacturer’s 
instructions. To study the activity of NF-κB in fresh livers, the DNA binding of p65 
was assessed using the TransAM NF-κB p65 ELISA kit (#40096, Active Motif, La Hulpe, 
Belgium) according to the manufacturer’s instructions.
iSOlAtiON Of BONe MArrOW CellS AND PeritONeAl MACrOPHAGeS
Bone marrow cells isolated from either WT or Commd1∆Mye mice were cultured 
and differentiated into macrophages, as described previously [25]. Peritoneal macrophages 
were isolated 3 days after injection of 4% thioglycolate in the peritoneal cavity of either WT 
or Commd1∆Mye mice. 
iMMUNOBlOt ANAlySiS
Tissues were homogenized in NP40 buffer [0.1% Nonidet P-40 (NP-40), 0.4 M NaCl, 
10 mM Tris-HCl (pH 8.0), 1 mM EDTA] supplemented with protease and phosphatase 
5COMMD1 in liver inflammation and steatosis
95
inhibitors and 30 μg of protein was loaded per gel lane. Samples were separated using 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred 
to Amersham™ Hybond™-P PVDF Transfer Membrane (#RPN303F, GE Healthcare, Diegem, 
Belgium). Bands were visualized using ChemiDoc™ XRS+ System (Bio-Rad Laboratories 
BV, Veenendaal, the Netherlands).
liVer liPiD eXtrACtiON
15% (w/v) liver homogenates were prepared in 1x PBS and lipid extraction 
was performed using the Bligh & Dyer method [26]. Samples were analyzed 
for cholesterol and triglyceride content.
CHOleSterOl AND triGlyCeriDe ANAlySiS iN PlASMA AND liVer liPiD SAMPleS
Total cholesterol (TC) levels were determined using a colorimetric assay (11489232, Roche 
Molecular Biochemicals) with cholesterol standard FS (DiaSys Diagnostic Systems Gmbh, 
Holzheim, Germany) as a reference. Triglyceride (TG) levels were determined using Trig/
GB kit (1187771, Roche Molecular Biochemicals) with Roche Precimat Glycerol standard 
(16658800) as a reference.
ANtiBODieS 
In these experimental procedures we used the following antibodies: rabbit polyclonal 
antibody against COMMD1 (11938-1-AP, Proteintech Group, USA), mouse anti-β-Actin 
(A5441, Sigma-Aldrich Chemie B.V., Zwijndrecht, the Netherlands), rabbit antiTubulin 
(AB4047, Abcam, Cambridge, UK), rabbit anti-Lamin A/C (2032, Cell Signaling 
Technology Europe, B.V., Leiden, the Netherlands), rabbit anti-p65 (4764, Cell Signaling 
Technology, Europe, B.V.), rabbit anti-IκBα (sc-371, Santa Cruz Biotechnology Inc., 
Heidelberg, Germany), rabbit anti-Cd68 (#137002, Biolegio, Nijmegen, the Netherlands) 
rabbit anti-F4/80 (#101201, Biolegio, Nijmegen, the Netherlands), goat anti-rabbit IgG 
(H + L)-HRP Conjugate (170-6515, Bio-Rad Laboratories BV, Veenendaal, the Netherlands), 
goat anti-mouse IgG (H + L)-HRP Conjugate (170-6516, Bio-Rad Laboratories BV). 
liVer HiStOlOGy
Paraffin-embedded liver sections (4 μm) were stained with Hematoxylin & Eosin (H&E). 
Snap-frozen liver sections (5 μm) were stained using Oil Red O (ORO) or antibodies against 
Cd68. F4/80 staining was performed on either paraffin-embedded or snap-frozen liver 
sections. Scoring of steatosis and lobular inflammation was performed in an unbiased manner 




Pieces of murine liver of approximately 100 mg were homogenized in 1 ml QIAzol Lysis Reagent 
(Qiagen, Venlo, the Netherlands). Total RNA was isolated by chloroform extraction. Isopropanol-
precipitated and ethanol-washed RNA pellets were dissolved in RNase/DNase free water. 1 μg 
of RNA was used to prepare cDNA with the Quantitect Reverse Transcription Kit (Qiagen, 
Venlo, the Netherlands) according to the protocol provided by the manufacturer. 20 ng cDNA 
was used for subsequent quantitative real-time PCR (qRT-PCR) analysis using iTaq SYBR 
Green Supermix with ROX (Bio-Rad Laboratories BV,) and 7900HT Fast Real-Time PCR 
System (Applied Biosystems). The following PCR program was used: 500C/2 min., 950C/10 min., 
40 cycles of 950C/15 sec and 600C/1 min. Expression data were analyzed using SDS 2.3 software 
(Applied Biosystems) and the standard curve method of calculation. Mouse Cyclophilin  A 
was used as an internal control gene. The primer sequences we used are listed in Table S1.
StAtiStiCAl ANAlySiS
All results are expressed as mean ± SEM. Statistical analysis was performed using 
Prism 5.00 for Windows (GraphPad Software, CA, USA) and the unpaired Student’s t test. 
Results of P < 0.05 were considered to be statistically significant.
RESUlTS
HePAtiC DePletiON Of COMMD1 reSUltS iN iNCreASeD leVelS Of Nf-κB SUBUNit P65
To elucidate the role of hepatic Commd1 in NF-κB signaling and inflammation in vivo, 
we depleted Commd1 in hepatocytes (Commd1∆Hep) by crossing Commd1loxP/loxP mice 
with Alb-Cre transgenic mice, mice expressing Cre-recombinase in adult hepatocytes [12]. 
Commd1∆Hep mice showed marked reduction in hepatic Commd1 levels, however some 
residual amount of Commd1 was detected (Fig. 1A), which is likely due to the expression 
of Commd1 in nonparenchymal cells, as approximately 80% of an adult liver genome exists 
in hepatocytes, the rest is located in endothelial, stellate or Kupffer cells [28]. 
Since various cellular models demonstrated that down-regulation of COMMD1 results 
in elevated p65 levels and subsequently increased NF-κB activity [1, 13], we first assessed 
the levels of p65 in nuclear and cytosolic fractions of livers from WT (n=6) and Commd1∆Hep 
mice (n=6-8) (Fig. 1A). We observed that Commd1∆Hep mice showed clearly higher protein 
levels of p65 in both the cytosolic and nuclear fractions of livers compared with WT mice.
Next, we determined whether the rise in protein p65 levels was caused by an increase 
in p65 mRNA levels (Fig. 1B). We detected no difference in hepatic p65 gene expression 
between Commd1∆Hep mice and WT littermates, excluding the possibility that the increase 
in p65 protein levels was due to alterations in transcriptional regulation. In line 
with previous in vitro studies [1, 13], these data suggest that Commd1 depletion results 
in an increased protein stability of p65 in hepatocytes.






























Figure 1. Commd1 mediates the levels of cytosolic and nuclear p65 in hepatocytes. (A) Fresh 
livers from chow-fed WT and Commd1∆Hep mice were used to isolate nuclear and cytosolic fractions, 
then p65 levels were determined by immunoblot analysis. Three representative mice per group are 
shown. (B) Relative mRNA expression of p65 in livers of WT and Commd1∆Hep mice, as determined 
by quantitative RT-PCR. All values per group are shown as mean ± SEM. 
HePAtiC COMMD1 DePletiON AGGrAVAteS SteAtOSiS, BUt NOt iNflAMMAtiON
Since NF-κB-mediated inflammation is associated with the progression of NAFLD towards 
a more severe NASH phenotype [29-31], we investigated the consequences of elevated p65 
levels in hepatic Commd1-deficient mice on inflammation in a mouse model of NAFLD 
nduced by an HFC diet. After 12 weeks of HFC feeding, we saw no differences in body 
and liver weight between Commd1∆Hep and WT mice (Fig. 2A). In addition, no liver damage was 
observed, as the plasma levels of the liver enzymes ALT and AST were not markedly increased 
(data not shown). Surprisingly however, total hepatic cholesterol and triglyceride levels were 
significantly increased in the Commd1∆Hep mice following 12 weeks of HFC diet (Fig. 2B). 
This observation was supported by histological analysis: hematoxylin and eosin (H&E) 
staining  demonstrated an increase in lipid deposits in the livers of Commd1∆Hep mice (Fig. 2C, D), 
as  confirmed by ORO staining (Fig. 2C). These differences were not seen in chow-fed animals.
Histologically, HFC-feeding markedly increased the level of lobular inflammation in both WT 
and Commd1∆Hep mice, but no alterations between the genotypes were seen (Fig. 2E).
In order to investigate the effect of Commd1 loss in hepatocytes on inflammation in greater 
detail, we performed immunohistochemical stainings. Immunostaining for the macrophage 
markers [32] Cd68 (a marker of activated macrophages [33]) and F4/80 (marker of mature 
macrophages, highly expressed by Kupffer cells [33]) showed increased infiltration of macrophages 
in the livers on HFC feeding (Fig. 3A), but we saw no differences between Commd1∆Hep 
and WT mice. Expression analysis of Cd68 and F4/80, together with Cd11b, a migratory marker 


















































































































Figure 2. Hepatic Commd1 deficiency aggravates lipid accumulation in HFC-fed mice. (A) Body 
weight (BW) and liver weight, represented as % of the BW, of WT and Commd1∆Hep mice after 12 weeks 
on HFC diet and of control chow-fed groups. (B) Hepatic total cholesterol and triglyceride levels. Liver 
lipids were extracted from snap-frozen mouse livers using the Bligh-Dyer method for lipid extraction 
and analyzed with a colorimetric assay. (C) H&E and ORO staining of hepatic tissue from 4-hour fasted 
chow- and HFC-fed mice. H&E staining was performed on paraffin-embedded samples and ORO 
staining on snap-frozen hepatic cryo-sections. Representative images per group are shown. Scale bars 
represent 100 μm. (D) Histological evaluation of liver steatosis. Steatosis was not present in chow-fed 
mice (N.D. = not detected). (E) Histological evaluation of inflammation. Inflammation score was based 
on the number of inflammatory foci per five random fields at 200x. All values per group are shown as 
mean ± SEM. Statistical significance was determined versus WT control mice: *P<0.05, **P<0.01. 
Next, hepatic mRNA levels of a number of NF-κB target genes were determined (Fig. 3C). 
A significant increase in the expression of the proinflammatory genes: Tnfα, Il-1α, Il-1β 
and Mcp1, and the NF-κB target genes: Icam, and Tnfaip3 (A20) was detected following 
12 weeks of HFC feeding, but we saw no differences between Commd1∆Hep and WT mice, 
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Figure 3. Depletion of hepatocyte Commd1 has no effect on HFC-diet-induced liver inflammation. 
(A) Immunostaining of WT and Commd1∆Hep livers. Snap-frozen samples were stained for the 
macrophage markers Cd68 and F4/80. Representative images per group are shown. Scale bars represent 
100 μm. Relative liver mRNA expression of (B) the macrophage and monocyte markers Cd68, Cd11b 
and F4/80, and (C) proinflammatory cytokines and NF-κB target genes, Tnfα, Il-1α, Il-1β, Mcp-1, Icam, 
IκBα (NFκBia), and A20 (Tnfaip3). All values per group are shown as mean ± SEM. 
corroborating the histological analysis. In addition, no substantial difference in the expression 
of other NF-κB (Fig. S1A) or Commd genes was seen (Fig. S1B). Altogether, hepatic deficiency 
of Commd1 exacerbated HFC diet-induced steatosis, but not liver inflammation. 
Since Commd1 is involved in multiple physiological processes [3, 11, 35], 
it is possible that dietary intervention in combination with Commd1 deficiency affects 
additional pathways that modulate diet-induced liver inflammation, independent of its role 
in NF-κB signaling, leading to the observed results. Therefore, we decided to use a genetic 
approach to further evaluate the role of hepatocyte Commd1 in NF-κB-mediated liver 
inflammation. We crossed Commd1∆Hep mice on a p55∆ns/∆ns genetic background (p55∆ns/∆ns ; 
Commd1∆Hep). The p55∆ns/∆ns mice are homozygous for a mutation in the gene encoding 
the tumor necrosis factor receptor 1 (Tnfr1). This mutation results in impaired shedding 
of the Tnfr1 from the cell surface, resulting in increased activation of NF-κB and chronic, low-
grade inflammation in the liver [24, 36]. The p55∆ns/∆ns ; Commd1∆Hep mice were born without any 
overt phenotype and in the expected Mendelian ratios. No differences in body and liver weight 
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Figure 4. Loss of Commd1 function in hepatocytes does not increase Tnf-induced NF-κB activity. 
(A) Body weight (BW) and (B) liver weight (represented as %BW) of chow-fed p55∆ns/∆ns and p55∆ns/∆ns ; 
Commd1∆Hep mice. (C) Cytosolic levels of hepatocyte p65 and IκBα (NFκBia) and nuclear levels 
of hepatocyte p65 of three representative mice per group of p55∆ns/∆ns and p55∆ns/∆ns ; Commd1∆Hep 
mice determined by immunoblot analysis. (D) Relative gene expression of p65 in liver of p55∆ns/∆ns 
and p55∆ns/∆ns ; Commd1∆Hep mice, determined by qRT-PCR. (E) H&E staining of hepatic tissue 
from chow fed mice after 4-hour fasting. Representative images per group are shown. Inflammatory 
foci are marked with arrows. Scale bars represent 100 μm. (F and G) Relative mRNA expression 
of (F) proinflammatory cytokines, marcophages markers, and (G) anti-apoptotic genes, as determined 
by qRT-PCR. All values per group are shown as mean ± SEM. Statistical significance was determined 
versus control p55∆ns/∆ns group. *P<0.05
Commd1 ablation in p55∆ns/∆ns mice also resulted in elevated levels of p65 (Fig. 4C), with 
no alteration in p65 mRNA levels (Fig. 4D). Furthermore, similar to what we and others 
have previously shown [24, 36], p55∆ns/∆ns mice display a significant increase in the number 
of inflammatory foci within hepatic lobules (Fig. 4E). However, we saw no clear differences 
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in the number of inflammatory foci between p55∆ns/∆ns (n=6) and p55∆ns/∆ns; Commd1∆Hep 
mice (n=7) (Fig. 4E). This observation was corroborated by the fact that the gene expression 
of proinflammatory markers and cytokines was not affected by Commd1 deficiency (Fig. 4F). 
Only Il-1α mRNA levels were significantly increased, but the level of induction was rather mild. 
In addition to the NF-κB signaling pathway, TNF-α also activates apoptotic pathways [37, 38], 
and since NF-κB drives the expression of anti-apoptotic genes, we also looked at the mRNA 
levels of anti-apoptotic genes mediated by NF-κB (Fig. 4G). However, we saw no differences 
between the two groups (Fig. 4G). 
Altogether, using two independent but complementary approaches, we showed that 
depletion of Commd1 in hepatocytes leads to elevated levels of the NF-κB subunit p65, 
both in the nucleus and cytoplasm, but that it does not affect the level of liver inflammation 
induced by HFC-feeding nor in Tnf-mediated chronic hepatitis.
SteAtOSiS AND iNflAMMAtiON Are eXACerBAteD iN MyelOiD-DefiCieNt 
COMMD1 MiCe
In addition to hepatocytes, myeloid cells (in particular macrophages) also play a crucial role 
in NF-κB-mediated liver inflammation and in the progression of NAFLD [39]. We therefore 
assessed the role of myeloid Commd1 in liver inflammation during the development 
of steatohepatitis. We crossed mice carrying floxed conditional Commd1 alleles with 
LysM-Cre transgenic mice [23] to specifically ablate Commd1 in the myeloid lineage 
(Fig. S2A,B) [40]. We fed WT (n=6-7) and Commd1∆Mye mice (n=6-7) either chow or HFC 
diet for 12 weeks. Commd1 deficiency in myeloid cells did not lead to differences in body 
and liver weight, neither in chow- nor HFC-fed mice (Fig. 5A). The plasma levels of the 
liver enzymes ALT and AST were also not noticeably elevated (data not shown). However, 
HFC-fed Commd1∆Mye mice showed a significant increase in liver triglyceride levels 
compared to WT mice (Fig. 5B). H&E staining of the livers corroborated the exacerbated 
liver steatosis in Commd1∆Mye mice, and was further confirmed by ORO staining (Fig. 5C, D). 
In addition to the elevated hepatic fat deposits, histological scoring also revealed 
an increase in hepatic inflammation (Fig. 5E). The microscopic appearance of the livers 
showed inflammatory foci widespread in the hepatic tissue. We therefore investigated 
the effect of myeloid Commd1 depletion on liver inflammation in more detail. We stained 
liver sections of Commd1∆Mye and WT mice for Cd68 and F4/80 (Fig. 6A). Histological scoring 
showed an increase in the number of inflammatory foci in Commd1∆Mye mice following 
12 weeks of HFC feeding. Moreover, this observation was confirmed by mRNA expression 
analysis (Fig. 6B). In addition, we analyzed the expression of various proinflammatory 
cytokines regulated by NF-κB, such as Tnf, Mcp-1, Ccl5 and Icam (Fig. 6C). Dietary intervention 
markedly induced the expression of proinflammatory markers in both groups. Compared 
to WT mice, Commd1∆Mye mice showed a significant increase in mRNA expression of most 













































































































Chow      HFC
Figure 5. Myeloid Commd1 deficiency exacerbates HFC-induced lipid accumulation.
(A) Body weight (BW) and liver weight, represented as % of BW, of WT and Commd1∆Hep mice after 
12 weeks on HFC diet and of control chow-fed groups. (B) Hepatic total cholesterol and triglyceride 
levels. (C) H&E and ORO staining of hepatic tissue from chow- and HFC-fed mice after 4-hour fasting. 
Representative images per group are shown. Scale bars represent 100 μm. (D) Histological evaluation 
of liver steatosis. Steatosis was not present in chow-fed mice (N.D. = not detected). (E) Histological 
evaluation of inflammation: inflammation score was based on the number of inflammatory foci per 
five random fields at 200x. All values per group are shown as mean ± SEM. Statistical significance 
was determined versus WT control group on each diet. *P<0.05.
a trend towards elevated expression (Fig. 6B, C). In conclusion, depletion of Commd1 
in myeloid cells leads not only to increased liver inflammation, but also exacerbates 
the progression of steatosis upon 12 weeks of HFC feeding.
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Figure 6. HFC diet-induced liver inflammation is increased upon depletion of myeloid Commd1.
(A) Immunohistochemistry staining of the macrophage markers Cd68 and F4/80. Representative images 
per group are shown. Scale bars represent 100 μm. (B and C) Relative mRNA expression of (B) macrophage 
and monocyte markers, and (C) proinflammatory cytokines. All values per group are shown as mean ± SEM. 
Statistical significance was determined versus WT control group on each diet. *P<0.05, **P<0.01. 
dISCUSSION
NF-κB signaling is an essential pathway in the progression of many inflammatory diseases, 
including NAFLD [41, 42]. It is therefore crucial to identify the genes and mechanisms 
regulating the NF-κB pathway, and these might lead to novel therapeutic strategies to treat 
NAFLD. COMMD1, a pleiotropic protein, is involved in various pathways including NF-κB 
signaling [1, 11]. Here we evaluated the extent Commd1 deficiency in either hepatocytes 
or macrophages contributes to liver inflammation and progression of NAFLD in mice. 
On the one hand we showed that Commd1 has a cell-type-specific role in controlling liver 
inflammation in NAFLD, since myeloid Commd1 deficiency, but not hepatocyte-specific 
deletion, augmented the inflammatory tone of the disease. On the other hand, we saw that 
depletion of Commd1 in either cell type exacerbated diet-induced hepatic lipid accumulation. 
Ablation of Commd1 in the myeloid lineage caused increased diet-induced steatosis 
and liver inflammation concomitant with the elevated expression of several inflammatory 
cytokines, in particular Tnfα. Kupffer cells are the main source of hepatic TNFα, which has 
been shown to be an essential cytokine in the progression of NAFLD [39]. Blocking the 
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Tnfα signaling pathway by deletion of either the Tnfr1 or Tnfα ameliorates NAFLD in mice 
[20, 43, 44]. In addition, leptin-deficient (Ob/Ob) mice treated with anti-TNFα antibodies 
show a reduced level of liver steatosis [45-47]. The increased lipid accumulation observed 
in HFC-fed Commd1∆Mye mice might therefore be explained by the elevated Tnfα expression 
in these mice. Our observation of a higher inflammatory tone in the liver of HFC-fed 
Commd1∆Mye mice is in line with our recent study [40], in which we showed that myeloid 
depletion of Commd1 exacerbates dextran sodium sulfate (DSS)-induced colitis and increases 
the susceptibility to sepsis because it invokes a stronger inflammatory response. Furthermore, 
Commd1 deficiency in bone-marrow derived myeloid cells selectively altered the expression 
of LPS-mediated genes, including a subset of genes involved in the immune response, 
and genes directly regulated by NF-κB [40]. However, these expression data also 
demonstrated that in addition to NF-κB, myeloid Commd1 also mediates other pathways 
activated by LPS, either directly or indirectly [40]. In addition, the intestinal epithelial-
deficient Commd1 mice do not show increased inflammation or any sensitivity difference 
in DSS-induced colitis, resembling some aspects of the hepatic-specific deficiency that we 
present here. 
Despite the elevated levels of cytosolic and nuclear p65 (Fig. 1A), Commd1 deficiency 
in hepatocytes did not affect the level of liver inflammation in either NAFLD (Fig. 3) or in mice 
with low-grade liver inflammation due to a mutation in Tnfr1 [24, 36]. Nonetheless, the increase 
in p65 levels is in line with previous in vitro studies [1, 13], which demonstrated that COMMD1 
promotes the ubiquitin-mediated proteolysis of p65. Insufficiency of COMMD1 in U2OS cells 
[13] or loss of p65-COMMD1 interaction [14] increased the steady-state and the protein stability 
of p65, respectively. Together with the unchanged mRNA levels of p65 (Fig. 1B), these data suggest 
that the elevated p65 levels in Commd1-deficient hepatocytes may result from an increased protein 
stability of p65 caused by reduced p65 ubiquitination. Nevertheless, independent of the level 
of hepatocyte p65, the activity of NF-κB is not changed upon depletion of Commd1 (Fig. 3C). 
A DNA-binding ELISA assay to assess the activity of NF-κB supported this observation. Although 
LPS injection itself significantly increased the activity of NF-κB in the livers of WT and Commd1∆Hep 
mice, Commd1 deficiency did not affect the level of NF-κB binding to DNA neither after PBS 
nor LPS (Fig. S3). The level of NF-κB activity is tightly titrated through various mechanisms 
[48-53] and numerous proteins controlling NF-κB signaling have been identified [11]; 
we therefore speculate that the effect of Commd1 loss is compensated by another mechanism 
to restore a basal NF-κB activity. We excluded the contribution of the well-known NF-κB 
inhibitors, IκBα (Nfkbia) and A20 (Tnfaip3) [11]. NF-κB drives the expression of both genes, 
but the mRNA levels of IκBα (Nfkbia) and A20 (Tnfaip3) in Commd1∆Hep livers of chow- 
and HFC-fed mice were not altered compared to WT mice (Fig. 3C). In line with this observation, 
we saw no difference in IκBα (Nfkbia) protein levels in p55∆ns/∆ns ; Commd1∆Hep mice (Fig. 4C). 
In addition, we saw no marked differences in the expression of other COMMD genes, a family 
of proteins, which have the ability to inhibit NF-κB activity [1, 11]. This suggests that there 
is another homeostatic mechanism that prevents uncontrolled NF-κB activity in Commd1-
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deficient hepatocytes, which requires further studies to identify the mechanism and 
understand what is happening.
Despite the lack of a higher inflammatory response, Commd1∆Hep mice fed a HFC-diet 
surprisingly showed elevated levels of liver cholesterol and triglycerides (TG) compared to WT 
littermates (Fig. 2B). Supported by histological analysis, these data indicate that hepatic 
Commd1 deficiency aggravates steatosis. Although COMMD1 has been linked to the regulation 
of biliary copper excretion and may regulate trafficking of various transporters [2, 9, 54], 
including ATP7B, a P-type ATPase which mediates copper excretion into the bile [55], 
we could not observe any marked changes in the biliary cholesterol excretion determined 
by the in vivo Transintestinal Cholesterol Excretion (TICE) experiment [56] (data not 
shown). Because we did not observe any marked changes in the mRNA levels of various 
genes involved in lipid uptake, synthesis and excretion (data not shown), a clear explanation 
for this observation is still missing. However, as COMMD1 is associated with the intracellular 
trafficking of various proteins and is localized to vesicles (reviewed in [3]), we speculate that 
COMMD1 acts as an adaptor protein in sorting/fusion of vesicles, a process that is also involved 
in autophagy. Recent studies demonstrated that inhibition of macroautophagy is associated 
with accumulation of TG and cholesterol in lipid droplets [57, 58]. It would therefore be 
of interest to further investigate the hepatic function of COMMD1, and to determine 
which kind of vesicles COMMD1 is localized to. Although COMMD1 partially co-localizes 
to endosomal and lysomal markers (reviewed in [3]), COMMD1-associated vesicles are still 
not fully characterized. Based on its pleiotropic function, it is highly possible that COMMD1 
is not only involved in biliary copper excretion, but requires further substantial investigation.
In conclusion, in this study we demonstrate that Commd1 represses the level 
of inflammation in NAFLD in a cell-type-dependent manner. Although hepatocyte 
Commd1 does not play a major role in liver inflammation, our data indicate that it does 
have a protective role in slowing the progression of steatosis in mice. Furthermore, our 
current knowledge advocates that its repressive action on inflammation is restricted to 
myeloid cells and this seems to be a general phenomenon in various disease models [40]. 
The mechanism by which myeloid COMMD1 restrains inflammation might therefore be 
an interesting target for developing new treatment strategies for inflammatory diseases.
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SUPPLEMENTARy TABLES
Table S1. qRT-PCR primer sequences.









A20 (Tnfaip3) GCTCTGAAAACCAATGGTGATG CCGAGTGTCTGTCTCCTTAAG
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Figure S1. Hepatic Commd1 deficiency does not affect the gene expression of the NF-κB subunits 
or Commd family members. Relative mRNA expression of (A) NF-κB subunits and (B) Commd 
family members in livers of WT and Commd1∆Hep mice, as determined by quantitative RT-PCR. 
All values per group are shown as mean ± SEM. Statistical significance was determined versus WT 



































Figure S2. Commd1∆Mye mice show efficient depletion of Commd1 in macrophages. Relative 
mRNA expression of Commd1 in (A) peritoneal and (B) bone marrow-derived macrophages of WT 
(n=3) and Commd1∆Mye (n=3) mice. Statistical significance was determined versus WT control mice: 
**P<0.01, ***P<0.001


















Figure S3. Depletion of hepatic Commd1 does not effect NF-κB activity. Binding of nuclear NF-κB 
to the DNA was assessed in livers of WT (n=4) and Commd1∆Hep (n=4) mice after 6  h of LPS 
(10 mg/kg) administration. Statistical significance was determined versus WT mice in either control 
(PBS) or LPS-stimulated group: *P<0.05.

